Perrigo Company plc

NYSE:PRGO

Sector

🛒 Consumer Staples

Industries

🧴 Personal Care

🏬 Consumer Packaged Goods

💄 Cosmetics

🛍 Specialty Retail

Location

Ireland

Market Cap

USD 3.65 B

Share Price

USD 26.54

Avg Daily Volume

1,499,352

Change (1 day)

-0.11%

Change (1 year)

4.37%

Change (YTD)

3.23%

Perrigo Company plc Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 29, 2025: USD 109.90 M

Perrigo Company plc Research and Development (R&D) Expenses is USD 109.90 M for the Trailing 12 Months (TTM) ending March 29, 2025, a -8.72% change year over year. Research and development (R&D) expenses are the costs associated with the development of new products, technologies, or improvements to existing products.

Perrigo Company plc Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 120.40 M, a -3.68% change year over year.
Perrigo Company plc Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 125.00 M, a 3.99% change year over year.
Perrigo Company plc Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending April 02, 2022 was USD 120.20 M, a -27.98% change year over year.
Perrigo Company plc Research and Development (R&D) Expenses for the Trailing 12 Months (TTM) ending April 03, 2021 was USD 166.90 M, a -11.79% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

Key data

Date	Research and Development (R&D) Expenses	Revenue	Revenue	Gross Profit

NYSE: PRGO

Perrigo Company plc

CEO	Mr. Patrick Lockwood-Taylor
IPO Date	Dec. 17, 1991
Location	Ireland
Headquarters	The Sharp Building
Employees	8,379
Sector	🛒 Consumer Staples
Industries Personal Care 🏬 Consumer Packaged Goods 💄 Cosmetics 🛍 Specialty Retail

Description

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.